Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles County
- Disease/Condition
- Hypertension
- Drug/Device/Intervention
- Patient-focused strategies
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- University of California, Los Angeles
- Location
- Sylmar, United States of America
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Jun 01, 2027
- Enrollment
- 540 participants
Overall provider adoption of evidence based practices
The goal of the study is to promote equitable hypertension (HTN) management across the
 diverse patient population found in Los Angeles County Department of Health Services (LAC
 DHS) clinics.
 
 To achieve this goal, the study team will conduct provider- and patient-focused outreach
 strategies to understand how to best support adoption of blood pressure management practices
 already available within LAC DHS.
 
 LAC DHS clinics will be randomly assigned to one of three study conditions: 1)
 provider-focused outreach, 2) patient-focused outreach, and 3) usual outreach. The study will
 occur across 3 years with patient- and provider-focused outreach occurring in Year 1 and 2.
 In Year 3, study initiated patient- and provider-focused outreach will stop, and clinic use
 of patient- and provider-focused outreach practices will be observed by the study team.
 
 Provider-focused outreach includes increasing cultural awareness of factors that hinder and
 support blood pressure control, increasing access to blood pressure medications, and
 providing blood pressure management education. Patient-focused outreach includes using
 culturally sensitive educational materials and reminders to improve patient understanding of
 blood pressure, education on how to manage the condition, and increasing awareness of
 available blood pressure management resources. Clinics assigned to the usual outreach
 condition will operate as per usual in Year 1 but will receive patient- and provider-focused
 outreach in Year 2.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06359691
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06359691 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Los Angeles and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 540 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.